Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones
15 nov. 2021 08h00 HE
|
Cocrystal Pharma, Inc.
Submitted pre-IND briefing package to the FDA for intranasal/pulmonary CDI-45205 for the treatment of COVID-19 and sets goal of initiating IND-enabling study and Phase 1 in 2022Advance oral COVID-19...
Hepatitis B Clinical Landscape Market Report 2021: GlaxoSmithKline Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by Gilead
18 juin 2021 05h23 HE
|
Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Hepatitis B" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Hepatitis B market,...
Global Zika Virus Market Pipeline Spotlight Report 2021
04 juin 2021 07h08 HE
|
Research and Markets
Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Zika virus" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Zika virus market,...